SCHEMBL6265264

SCHEMBL6265264

COc1ccc2c(c1)CCc1c(C(F)(F)F)nn(-c3ccc(C(N)=O)cc3)c1-2

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.53
PTGS2 P35354 2/20 0.53
MAPT P10636 2/20 0.52
ALDH1A1 P00352 1/20 0.52
POLB P06746 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
F10 P00742 14/20 0.50
RAD52 P43351 1/20 0.50
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
USP2 O75604 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
F2 P00734 2/20 0.48
CCNA2 P20248 1/20 0.46
CDK2 P24941 1/20 0.46
CCNA1 P78396 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5698752 0.91 MAPT (0.59) PTGS1PTGS2MAPTALDH1A1POLB
SCHEMBL6353347 0.85 PTGS2 (0.72) PTGS1PTGS2F10
SCHEMBL8735027 0.76 PTGS2 (0.59) PTGS1PTGS2F10F2
SCHEMBL6793988 0.75 CCNA2 (0.62) F10RAD52F2CCNA2CDK2
SCHEMBL11868715 0.75 RAD52 (0.68) MAPTALDH1A1RAD52KDM4EMEN1
SCHEMBL11867763 0.74 RAD52 (0.70) PTGS1PTGS2MAPTALDH1A1RAD52
SCHEMBL7230422 0.74 PTGS1 (0.47) PTGS1PTGS2
SCHEMBL6339161 0.73 PTGS2 (0.74) PTGS1PTGS2
SCHEMBL6487680 0.73 CCNA2 (0.55) PTGS1PTGS2RAD52KDM4EMEN1
SCHEMBL6352140 0.73 RAD52 (0.56) PTGS1PTGS2ALDH1A1RAD52SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed